Precigen, Inc. Files 8-K: Director Changes & Officer Compensation Updates

Ticker: PGEN · Form: 8-K · Filed: Jun 30, 2025 · CIK: 1356090

Precigen, Inc. 8-K Filing Summary
FieldDetail
CompanyPrecigen, Inc. (PGEN)
Form Type8-K
Filed DateJun 30, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, executive-compensation, board-changes

TL;DR

Precigen's 8-K: Director shuffle, exec pay changes, and shareholder votes are on the docket.

AI Summary

On June 26, 2025, Precigen, Inc. filed an 8-K report detailing several key events. The company announced the departure of a director, the election of a new director, and updates to compensatory arrangements for certain officers. Additionally, the filing covers the submission of matters to a vote of security holders and includes financial statements and exhibits.

Why It Matters

This filing provides crucial updates on corporate governance and executive compensation, which can impact investor confidence and the company's strategic direction.

Risk Assessment

Risk Level: medium — Changes in directorship and executive compensation can signal internal shifts or strategic realignments that may carry inherent risks.

Key Players & Entities

  • Precigen, Inc. (company) — Registrant
  • June 26, 2025 (date) — Date of earliest event reported
  • Virginia (jurisdiction) — State of incorporation
  • 20374 Seneca Meadows Parkway, Germantown, Maryland 20876 (address) — Principal executive offices

FAQ

Who has departed from Precigen, Inc.'s board of directors?

The filing indicates the departure of a director, but the specific name is not provided in the summary text.

Has Precigen, Inc. elected any new directors?

Yes, the filing states that a new director has been elected.

What other items are covered in this 8-K filing?

The filing also covers updates to compensatory arrangements of certain officers, submission of matters to a vote of security holders, and includes financial statements and exhibits.

What is the exact date of the earliest event reported in this filing?

The earliest event reported is dated June 26, 2025.

What is Precigen, Inc.'s principal executive office address?

Precigen, Inc.'s principal executive offices are located at 20374 Seneca Meadows Parkway, Germantown, Maryland 20876.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 30, 2025 regarding PRECIGEN, INC. (PGEN).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.